P
3.47
-0.09 (-2.53%)
| Penutupan Terdahulu | 3.56 |
| Jumlah Dagangan | 4,223,250 |
| Harga / Jualan (P/S) | 151.10 |
| Harga / Buku (P/B) | 0.320 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -3,603.30% |
| EPS Cair (TTM) | -1.61 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 146.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 113.31% |
| Nisbah Semasa (MRQ) | 4.78 |
| Aliran Tunai Operasi (OCF TTM) | -104.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -106.25 M |
| Pulangan Atas Aset (ROA TTM) | -40.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -115.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Prime Medicine, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.00 |
|
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 24.22% |
| % Dimiliki oleh Institusi | 56.84% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Casdin Capital, Llc | 30 Jun 2026 | 3,167,175 |
| Amova Asset Management Americas, Inc. | 30 Jun 2026 | 2,407,018 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |